They established that the activity of RP11-713B9.1 was undoubtedly connected with TSLC1 (a tumour suppressor gene), while the overexpression of RP11-713B9.1 led to a substantial overexpression of TSLC1. The gene discussed is CADM1; the disease is neoplasm.